Resources / Kaleo
kaleo, Inc., Labeler Code 60842, Covered Outpatient Drugs
Exclusively Available at the 340B Ceiling Price via Direct Customer Solutions,
LLC
On January 2, 2023, kaleo, Inc. (“Kaleo”), labeler code 60842, began
participating in the 340B Program under a newly executed Pharmaceutical Pricing
Agreement. Kaleo has elected to offer its covered outpatient drug products sold
under labeler code 60842 at the 340B Ceiling Price to qualifying 340B Covered
Entities and their contract pharmacy agents exclusively via a direct
distribution model through Kaleo’s third-party logistics provider Direct
Customer Solutions, LLC (“DCS”). DCS will accept orders and provide logistics,
invoicing, and customer support.
In order to purchase the selected products through DCS, an entity
needs to register eligible site(s) by visiting www.directcustomersolutions.com.
Covered Entities using a Third-Party Administrator (“TPA”) to manage orders and
inventory may continue to use their current system if that TPA has previously
registered with DCS. You may check with your TPA to determine if it is already
registered with DCS, or you may visit the DCS website for a list of registered
TPAs. If your TPA is not currently registered with DCS, you may contact DCS
directly to facilitate the enrollment of your TPA, including Electronic Data
Interchange (“EDI”) connectivity. Once registered, customers may place orders
with DCS via EDI, online at www.directcustomersolutions.com,
or by phone at
(731) 574-2060.
Kaleo is fully committed to both patient safety and compliance with
its Pharmaceutical Pricing Agreement with the Department of Health and Human
Services and the statutory requirements for the 340B Program and is ensuring
Kaleo covered outpatient drug products sold under labeler code 60842 are readily
available at the 340B Ceiling Price via DCS.
If you have any questions regarding this model or access to these
products, please contact DCS customer service at (731) 574-2060 or Kaleo
customer service at customersupport@kaleo.com.